← Back to Search

REMM-HIIT for Post-COVID-19 Critical Illness (REMMHIIT-COVID Trial)

N/A

Waitlist Available

Led By Paul Wischmeyer, MD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months post-discharge, 6 months post-hospital discharge

Awards & highlights

REMMHIIT-COVID Trial Summary

This trial is testing the feasibility of a new rehabilitation program for people who have been critically ill with COVID-19. The program uses high intensity interval training, which is a type of exercise that involves short bursts of very intense activity, followed by a brief rest period. The program will be remotely monitored and supported by mobile health technology.

Eligible Conditions

Coronavirus
Intensive Care Unit
Fitness Trackers
High Intensity Interval Training
Critical Illness

REMMHIIT-COVID Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months post-discharge, 6 months post-hospital discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months post-discharge, 6 months post-hospital discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-discharge, 6 months post-hospital discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Peak oxygen consumption (V02P) at 3 months after hospital discharge

Secondary outcome measures

Change in 6 minute walk test distance from baseline to 3 months after hospital discharge

Change in cognition from 3 months to 6 months after hospital discharge.

Change in cognition from baseline to 3 months after hospital discharge.

+5 more

Other outcome measures

Change in biomarkers of aging and resilience, and mitochondrial function from baseline to 3 months post-discharge

REMMHIIT-COVID Trial Design

2Treatment groups

Experimental Treatment

Group I: REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT)Experimental Treatment1 Intervention

REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT) The intervention consists of high intensity interval training, consisting of a 30-minute exercise session that includes 10 x 1-minute intervals of high intensity 3x/week (e.g., Monday, Wednesday, Friday) and supplemented with 2 sessions per week of strength, balance, and mobility exercises (e.g., Tuesday, Thursday). Exercise will be supported by an activity tracker, which will allow study personnel to track patient heart rates during exercise on a daily basis, allowing them to provide individualized feedback and coaching.

Group II: ComparatorExperimental Treatment1 Intervention

Patients randomized to the control arm will receive the same technology platform and education on exercise options, including HIIT, but will return home to exercise as they see fit without personalized instruction and coaching. They will be remotely monitored, but will not receive feedback unless any adverse events are noted

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT)

2022

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,358 Previous Clinical Trials

3,420,056 Total Patients Enrolled

Vanderbilt UniversityOTHER

703 Previous Clinical Trials

6,143,334 Total Patients Enrolled

Paul Wischmeyer, MDPrincipal InvestigatorDuke University

5 Previous Clinical Trials

521 Total Patients Enrolled

Media Library

Coronavirus Research Study Groups: REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT), Comparator

Coronavirus Clinical Trial 2023: REMotely Monitored, Mobile Health-Supported High Intensity Interval Training Highlights & Side Effects. Trial Name: NCT04664101 — N/A

REMotely Monitored, Mobile Health-Supported High Intensity Interval Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT04664101 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this clinical experiment still taking place?

"Affirmative. According to information on clinicaltrials.gov, this experiment is actively searching for participants - it was first announced on March 2nd 2022 and most recently updated on the 21st of that month. 20 volunteers are needed between two sites."

Answered by AI

How many individuals have opted in to the experiment?

"Correct. The clinicaltrial.gov webpage reveals that this trial is presently looking for participants, and was first published on March 2nd 2022 with a modification date of the 21st of the same month. There are 20 vacancies at two different research centres."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

REmotely Monitored, Mobile Health-Supported High Intensity Interval Training After COVID-19 Critical Illness (REMM-HIIT-COVID-19)

2022. "REmotely Monitored, Mobile Health-Supported High Intensity Interval Training After COVID-19 Critical Illness (REMM-HIIT-COVID-19)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04664101.